Serum levels and alpha1-antitrypsin phenotypes in active pulmonary tuberculosis

Area of Science:

• Pulmonary Medicine
• Genetics
• Biochemistry

Background:

• Alpha-1-antitrypsin (alpha1-AT) is a key proteinase inhibitor in the lung.
• Pulmonary tuberculosis (TBC) is a significant global health issue.
• Understanding host factors like alpha1-AT may offer insights into TBC susceptibility and progression.

Purpose of the Study:

• To investigate alpha1-AT phenotypes and serum levels in Greek patients with pulmonary TBC.
• To compare alpha1-AT levels in TBC patients with a control group.
• To explore potential associations between alpha1-AT phenotypes and TBC.

Main Methods:

• Starch-gel electrophoresis was used to determine alpha1-AT phenotypes.
• Radial immunodiffusion quantified serum alpha1-AT levels.
• A cohort of 100 Greek pulmonary TBC patients and a control group were analyzed.

Main Results:

• The mean serum alpha1-AT level in TBC patients was significantly lower (p < 0.005) than in controls.
• Specific alpha1-AT phenotypes were observed in the TBC patient group.
• The study identified a statistically significant difference in alpha1-AT levels related to TBC.

Conclusions:

• Pulmonary tuberculosis is associated with reduced serum alpha1-antitrypsin levels in the studied Greek population.
• The distribution of alpha1-AT phenotypes may play a role in the observed differences.
• Further research is warranted to elucidate the precise mechanisms linking alpha1-AT to TBC pathogenesis.